Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.

Oncotarget · 2016 · PMC5173101 · PMID 27248821

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP=0.05actually significant

However, the comparison of sunitinib vs combination did not reach statistical significance (P=0.05) likely due to the fact that the amount of viable tumor remaining for MVD analysis was extremely small in the combination treatment group and sunitinib treated tumors had low MVD.

also in 75,868 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.